Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis.
about
Monocytes in atherosclerosis: subsets and functionsAn oxidized lipid-peroxisome proliferator-activated receptor gamma-chemokine pathway in the regulation of macrophage-vascular smooth muscle cell adhesionCX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin.Regulation of atherogenesis by chemokines and chemokine receptorsHeterogeneity of lung mononuclear phagocytes in chronic obstructive pulmonary diseaseRole of CX3CR1 receptor in monocyte/macrophage driven neovascularizationHydrogen sulfide inhibits the development of atherosclerosis with suppressing CX3CR1 and CX3CL1 expressionThrombin and vascular inflammationMechanisms of mononuclear phagocyte recruitment in Alzheimer's diseaseInflammatory cell recruitment in cardiovascular disease: murine models and potential clinical applicationsInterleukin-15 inhibits smooth muscle cell proliferation and hyaluronan production in rat ductus arteriosusGreater fractalkine expression in mesenteric arteries of female spontaneously hypertensive rats compared with malesMonocyte recruitment during infection and inflammationContribution of vascular cell-derived cytokines to innate and inflammatory pathways in atherogenesis.Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.Heterogeneity of lung mononuclear phagocytes during pneumonia: contribution of chemokine receptorsGenome-wide microarray analyses identify the protein C receptor as a novel calcineurin/nuclear factor of activated T cells-dependent gene in vascular smooth muscle cell phenotypic modulation.Syk regulates multiple signaling pathways leading to CX3CL1 chemotaxis in macrophages.Diabetic conditions promote binding of monocytes to vascular smooth muscle cells and their subsequent differentiationCyclosporin A decreases apolipoprotein E secretion from human macrophages via a protein phosphatase 2B-dependent and ATP-binding cassette transporter A1 (ABCA1)-independent pathway.Genetic variants in platelet factor 4 modulate inflammatory and platelet activation biomarkers.Cytoskeletal confinement of CX3CL1 limits its susceptibility to proteolytic cleavage by ADAM10Genome-wide RNAi screen reveals ALK1 mediates LDL uptake and transcytosis in endothelial cells.CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration.Differential ligand binding to a human cytomegalovirus chemokine receptor determines cell type-specific motility.Search for an association between V249I and T280M CX3CR1 genetic polymorphisms, endothelial injury and preeclampsia: the ECLAXIR studyCX3CR1 deficiency does not influence trafficking of adipose tissue macrophages in mice with diet-induced obesity.Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root.The temporal dynamics of plasma fractalkine levels in ischemic stroke: association with clinical severity and outcomeInnate and adaptive immunity in atherosclerosis.Fractalkine (CX3CL1), GM-CSF and VEGF-a levels are reduced by statins in adult patients.Chemokines and angiogenesis in rheumatoid arthritis.Monocytes: protagonists of infarct inflammation and repair after myocardial infarctionChemokines and chemokine receptors in arthritis.Two polymorphisms in the Fractalkine receptor CX3CR1 gene influence the development of atherosclerosis: a meta-analysisCX3CL1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in mice.Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient miceRole of fractalkine/CX3CR1 interaction in light-induced photoreceptor degeneration through regulating retinal microglial activation and migrationNeferine inhibits angiotensin II-induced rat aortic smooth muscle cell proliferation predominantly by downregulating fractalkine gene expressionFractalkine is expressed in early and advanced atherosclerotic lesions and supports monocyte recruitment via CX3CR1.
P2860
Q22251045-3881EED1-BED5-4D44-8BCB-1B08FA403559Q24300694-41400486-05AE-4593-925F-2061FA1B8917Q24814510-2207F5C2-61BD-45A3-B389-DA3B46C3DA58Q27003124-D7DE3E07-A148-4E4C-A81D-228C31933A4EQ27014453-645542D1-98C5-4DF2-803D-A08585D4F358Q27313463-0A5BB1CA-76E1-41A9-A355-74B13356BFA8Q27332432-660B3AD1-638C-45D7-BE5C-882FCAD340DBQ28246124-F3E98FAD-DD41-4850-A1F0-051F3B64E902Q28275105-C4B271BD-72CA-4C75-A8E1-F27960229AAAQ28275259-454A2235-67A6-4ADE-944B-FF597B8339A4Q28567965-38C9EB7C-FA3C-4AC7-96B3-60F6D4BAB782Q28571899-53DAAA9B-1C21-417E-A36E-9A3AAC8F0E98Q29620067-2CB88440-5F2E-4A5F-BBDF-98CAA36694EEQ30318502-C6E8ABEB-AE1C-488C-8418-87156F24E0D1Q30319434-78A98955-2799-4B4D-89FB-554E66C95D0BQ30409523-3AA2CE37-8DDF-4DB0-A249-05B649758ED8Q30424180-1FAB8FD5-6B25-43BC-A7DA-EB93072A4932Q30427232-11EB6209-741C-4C04-84DA-64949EED40AFQ30433016-0A2AF9ED-8157-46C8-BC85-24A4554341FAQ30491848-A90AFDD5-A1EA-4623-A31D-9FDA9373A77DQ30559534-428D864F-F017-4620-A81D-125216DBF5EAQ30601949-6B67D77E-83A3-4201-986C-D21F5837F98AQ30829602-AEBA63E3-1031-44DD-9CF3-0C300E127D8EQ33301145-B1089234-5BA3-4A18-89C4-28AA9727FFBBQ33410786-BA461CB3-44E1-4FFA-BF4D-F20D5DAD5D0CQ33479988-68B90636-24CE-4377-A9BF-6F5672AE543BQ33554073-0C4592A1-08F2-4F3D-92E1-CB6AB8D63BBFQ33580505-0FDA84F1-116D-4CF1-AA59-4F2A93F2651BQ33615950-2B79A860-0BA3-4006-94D1-5F824B39CDB9Q33659705-FB9C4F18-52D9-48B6-8F95-941F04687D69Q33794941-8C3207CB-6D1D-4634-A38A-E2F774B6EE16Q33909030-EAC33905-9F72-42B1-9AA5-931668D507A2Q33942337-65A0F7A7-403C-4E9A-A2C0-6A1ADA739B44Q34051768-4A0080A7-C439-49BA-9A73-E99EDA7EA8CBQ34152811-4D620BFD-0C1D-4F36-9CFC-56B2DB104CC6Q34163933-C2B91088-161E-4CC6-A660-B94D91B03B5CQ34236802-B134928F-F154-494F-9D40-0AAADACE5393Q34247267-96FFDECF-1928-4659-86FF-9BEEEEBAB664Q34292590-E24F67C3-55FA-41FA-A4A6-34B50D4CB194Q34391705-E9C5ADAE-96B9-4BAA-AC68-42DCDF03EDE1
P2860
Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Decreased atherosclerosis in C ...... fractalkine in atherogenesis.
@ast
Decreased atherosclerosis in C ...... fractalkine in atherogenesis.
@en
Decreased atherosclerosis in C ...... fractalkine in atherogenesis.
@nl
type
label
Decreased atherosclerosis in C ...... fractalkine in atherogenesis.
@ast
Decreased atherosclerosis in C ...... fractalkine in atherogenesis.
@en
Decreased atherosclerosis in C ...... fractalkine in atherogenesis.
@nl
prefLabel
Decreased atherosclerosis in C ...... fractalkine in atherogenesis.
@ast
Decreased atherosclerosis in C ...... fractalkine in atherogenesis.
@en
Decreased atherosclerosis in C ...... fractalkine in atherogenesis.
@nl
P2093
P2860
P356
P1476
Decreased atherosclerosis in C ...... fractalkine in atherogenesis.
@en
P2093
Christopher A Haskell
Israel F Charo
Philippe Lesnik
P2860
P304
P356
10.1172/JCI15555
P407
P577
2003-02-01T00:00:00Z